13/02/2026
From February 10 to 13, 2026, our Zijian team attended WHX Labs Dubai (formerly Medlab Middle East) at the Dubai World Trade Centre. Marking the 25th anniversary of the exhibition, the event brought together over 850 exhibitors and more than 35,000 professional visitors worldwide to explore the future of laboratory innovation and precision diagnostics.
The exhibition hall was bustling with attendees throughout the event. As the first edition since its rebranding, WHX Labs Dubai has carried forward the industry influence accumulated by Medlab over more than two decades. Amid the global resonance of medical innovation, it serves as a stage for cutting-edge technologies, a hub for industry trust, and a catalyst for international collaboration.
At this exhibition, Zijian showcased a range of core IVD products and integrated solutions. Leveragingproduct advantages that are suitable for medical institutions and laboratories at all levels, we attracted numerous visitors to stop by for inquiries and in-depth discussions.
Our Hematology Series Hematology Analyzers include four core models: HEA-3000 3 Part Hematology Analyzer, HEA-5000 5 Part Hematology Analyzer, HEA 5000S Multifunctional Blood Analyzer, and HEA-5300 5 Part Hematology Analyzer with RET. They coverfrom basic screening in primary care settings to precise analysis in medium-to-high-end medical institutions. Featuring a fully automatic and intelligent design, the analyzers deliver high detection accuracy and easy operation, meeting the standardized laboratory requirements of healthcare facilities at different levels.
The Biochemistry Diagnosis Line focuses on the POCT concept. Compact and portable,requiring no complex supporting facilities, the devices efficiently detect multiple biochemical indicators including liver function, renal function, blood glucose, and electrolytes, adapting to mobile and on-site testing demands. Our new product — the Automated Biochemistry Analyzer For Vet — is specially designed for pet care and animal husbandry veterinary scenarios. It integrates rapid testing, multi-species adaptation, and intelligent operation to precisely respond to the growing demand for animal diagnosis and treatment.
Our Microbiology Diagnostic Testing products feature high sensitivity and specificity, enabling rapid qualitative and quantitative detection of pathogenic microorganisms. With standardized operation and easy result interpretation, they meet the needs for rapid screening and tracing of infectious diseases.
This trip to Dubai has brought us not only recognition for our products, but alsoexpanded opportunities for cooperation and strengthened bonds of trust. We had in-depth exchanges with new friends and reunited with old partners as intended — cooperation intentions and win-win consensus were consolidated through every handshake.
We sincerely thank all new and old friends who visited our booth SA.B39. Your full recognition and sincere feedback have given deeper meaning to this overseas exhibition journey. Zijian Bio will continue to deepen its presence in the IVD field, refine technologies, develop scenario-adapted solutions, and move forward hand-in-hand with global partners with a more complete product portfolio and demand-oriented service model.
Zijian Bio is committed to providing comprehensive in vitro diagnostic solutions, helping medical professionals achieve accurate diagnosis and making human life healthier.
WHX Labs Dubai 2026 has come to a successful conclusion. We look forward to meeting you at the next stop!